A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes

A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes

Abstract Background Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to β-interferon. It acts against CD52, leading primarily to lymphopenia. Recent data have shown that mild neutropenia is observed...

Full description

Bibliographic Details
Main Authors: A. G. Vakrakou, D. Tzanetakos, S. Valsami, E. Grigoriou, K. Psarra, J. Tzartos, M. Anagnostouli, E. Andreadou, M. E. Evangelopoulos, G. Koutsis, C. Chrysovitsanou, E. Gialafos, A. Dimitrakopoulos, L. Stefanis, C. Kilidireas
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Alemtuzumab
Neutropenia
Large granular cells
Online Access:http://link.springer.com/article/10.1186/s12883-018-1183-4

Internet

http://link.springer.com/article/10.1186/s12883-018-1183-4

Similar Items